Bain Capital Life Sciences Investors, LLC Aclaris Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $662 Million
- Q1 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 3,000,000 shares of ACRS stock, worth $3.09 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 3,500,000
14.29%
Holding current value
$3.09 Million
Previous $3.68 Million
1.22%
% of portfolio
0.56%
Previous 0.46%
Shares
3 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$9.68 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$5.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.08 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.38 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.37 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $68.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...